Literature DB >> 24609715

Comparison of rates of referral and diagnosis of axial spondyloarthritis before and after an ankylosing spondylitis public awareness campaign.

Andrew A Harrison1, Christoffel Badenhorst, Sandra Kirby, Douglas White, Josie Athens, Simon Stebbings.   

Abstract

The objective of this research is to measure the effect of a national ankylosing spondylitis (AS) public awareness campaign on numbers of referrals for suspected AS and numbers of cases diagnosed with axial spondyloarthritis (SpA). A television advertising campaign was conducted by Arthritis New Zealand in 2011 to raise public awareness of AS. A retrospective analysis was made of referrals received by the three rheumatology services 3 months before the campaign started and 3 months after the campaign ended. The age, gender, number of referrals for suspected AS and number of referrals resulting in a diagnosis of axial SpA were recorded. Independent analysis showed that the awareness campaign reached 82 % of the primary target audience. In the 3 months after the awareness campaign, there was a significant increase in referrals for suspected AS compared with the 3 months before the campaign (54 vs. 88, 63 %, p = 0.0056). Referrals for other conditions did not change. The number of referrals resulting in a diagnosis of axial SpA also increased (27 vs. 44, 63 %, p = 0.0576). The mean ages of the patients referred and of those diagnosed with axial SpA did not change. The male/female ratio was 1:1 among the referrals for suspected AS and 2:1 in referrals diagnosed with axial SpA, before and after the campaign. The Arthritis New Zealand AS public awareness campaign was associated with a significant increase in referrals to rheumatology services for suspected AS and an increase in the diagnosis of axial SpA in clinics.

Entities:  

Mesh:

Year:  2014        PMID: 24609715     DOI: 10.1007/s10067-014-2551-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  25 in total

1.  Can we stop progression of ankylosing spondylitis?

Authors:  Georg Schett; Martin Rudwaleit
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-06       Impact factor: 4.098

2.  Guilt, fear, stigma and knowledge gaps: ethical issues in public health communication interventions.

Authors:  Nurit Guttman; Charles T Salmon
Journal:  Bioethics       Date:  2004-11       Impact factor: 1.898

3.  What is the most important outcome parameter in ankylosing spondylitis?

Authors:  J Braun; J Sieper
Journal:  Rheumatology (Oxford)       Date:  2008-09-16       Impact factor: 7.580

4.  Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

Authors:  A Zink; J Braun; J Listing; J Wollenhaupt
Journal:  J Rheumatol       Date:  2000-03       Impact factor: 4.666

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  The natural disease course of ankylosing spondylitis.

Authors:  S Carette; D Graham; H Little; J Rubenstein; P Rosen
Journal:  Arthritis Rheum       Date:  1983-02

Review 7.  Are there gender differences in severity of ankylosing spondylitis? Results from the PSOAS cohort.

Authors:  Wonuk Lee; John D Reveille; John C Davis; Thomas J Learch; Michael M Ward; Michael H Weisman
Journal:  Ann Rheum Dis       Date:  2006-11-24       Impact factor: 19.103

8.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

9.  Female patients with ankylosing spondylitis: analysis of the impact of gender across treatment studies.

Authors:  Irene E van der Horst-Bruinsma; Debra Jeske Zack; Annette Szumski; Andrew S Koenig
Journal:  Ann Rheum Dis       Date:  2012-12-22       Impact factor: 19.103

10.  Diagnostic delay in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: results from the Danish nationwide DANBIO registry.

Authors:  Jan Sørensen; Merete Lund Hetland
Journal:  Ann Rheum Dis       Date:  2014-02-17       Impact factor: 19.103

View more
  2 in total

1.  Screening and referral for axial spondyloarthritis--need of the hour.

Authors:  Abhijeet Danve; Atul Deodhar
Journal:  Clin Rheumatol       Date:  2015-05-07       Impact factor: 2.980

2.  Evaluation of multiple referral strategies for axial spondyloarthritis in the SPondyloArthritis Caught Early (SPACE) cohort.

Authors:  Ozair Abawi; Rosaline van den Berg; Désirée van der Heijde; Floris A van Gaalen
Journal:  RMD Open       Date:  2017-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.